EC Number |
Inhibitors |
Structure |
---|
2.3.2.13 | (1Z)-2-{[3-(3-fluorophenyl)-5-(2-methoxyphenyl)-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-2-yl]sulfanyl}ethanehydrazonic acid |
- |
|
2.3.2.13 | (2-tert-butoxy-2-oxoethyl)(dimethyl)sulfonium |
- |
|
2.3.2.13 | (2-[[(1R)-3-[4-[(benzyloxy)carbonyl]piperazin-1-yl]-1-carboxy-3-oxopropyl]amino]-2-oxoethyl)(dimethyl)sulfanium bromide |
- |
|
2.3.2.13 | (2-[[4-(methoxycarbonyl)benzyl]oxy]-2-oxoethyl)(dimethyl)sulfonium |
- |
|
2.3.2.13 | (2-[[6-(methoxycarbonyl)naphthalen-2-yl]methoxy]-2-oxoethyl)(dimethyl)sulfonium |
- |
|
2.3.2.13 | (2E)-3-(4-nitrophenyl)-1-(pyridin-3-yl)prop-2-en-1-one |
reversible, competitive with the acyl donor substrate |
|
2.3.2.13 | (2S)-2-[[(benzyloxy)carbonyl]amino]-4-[(prop-2-enoyl)amino]butanoic acid |
- |
|
2.3.2.13 | (2S,4R)-quinolin-3-ylmethyl 2-((((S)-3-bromo-4,5-dihydroisoxazol-5-yl)methyl)carbamoyl)-4-(2-hydroxybenzamido)pyrrolidine-1-carboxylate |
- |
|
2.3.2.13 | (2S,4R)-quinolin-3-ylmethyl 2-((((S)-3-bromo-4,5-dihydroisoxazol-5-yl)methyl)carbamoyl)-4-(3-hydroxybenzamido)pyrrolidine-1-carboxylate |
- |
|
2.3.2.13 | (2S,4R)-quinolin-3-ylmethyl 2-((((S)-3-bromo-4,5-dihydroisoxazol-5-yl)methyl)carbamoyl)-4-(4-hydroxybenzamido)pyrrolidine-1-carboxylate |
- |
|